MDedge, a medical publication, on Friday reported that hydroxychloroquine (HCQ) is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut.
from US News Headlines, Latest USA News, America Breaking News - Times of India https://ift.tt/3aVqFqf
from US News Headlines, Latest USA News, America Breaking News - Times of India https://ift.tt/3aVqFqf
Comments
Post a Comment